Low-Intensity Vibration to Reduce Symptoms and Improve Physical Functioning in Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy: A Pilot Randomized Trial
LIV is safe, feasible, and shows preliminary efficacy for CIPN symptom relief and improving physical functioning in cancer survivors with CIPN.
Authors
- Nathan F. Dieckmann (ORCID: https://orcid.org/0000-0001-5061-9889)
- Eric Roeland (ORCID: https://orcid.org/0000-0002-3674-3573)
- Fay Bahling Horak (ORCID: https://orcid.org/0000-0001-7704-5459)
- Stephanie M. Krasnow (ORCID: https://orcid.org/0000-0003-0507-4669)
- Sydnee Stoyles (ORCID: https://orcid.org/0000-0001-6755-0902)
- Kerri M. Winters‐Stone (ORCID: https://orcid.org/0000-0003-1706-8020)
- Clinton T. Rubin (ORCID: https://orcid.org/0000-0003-0909-7999)
- K. Braun
Institutions
- Oregon Health & Science University (US)
- Motion Control (United States) (US)
- Stony Brook University (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1200/op-24-00961
- Citations
- 1
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.05